Search for: "AstraZeneca Inc."
Results 261 - 280
of 340
Sort by Relevance
|
Sort by Date
23 Jul 2009, 3:15 am
In J & J Sports Productions, Inc. v. [read post]
23 Jun 2009, 2:44 pm
The agency also studied trials involving two other medicines that work by blocking inflammation-causing proteins called leukotrienes, AstraZeneca Pls's Accolate (zafirlukast) and Zyflo (zileuton) sold by Cornerstone Therapeutics Inc. [read post]
17 Jun 2009, 5:27 am
According to the Food and Drug Administration, drugs including Singulair, AstraZeneca Plc’s Accolate and Cornerstone Therapeutics Inc’s Zyflo and Zyflo CR may cause agitation, aggression, suicidal thinking, suicide, depression, insomnia and irritability. [read post]
8 Jun 2009, 6:46 am
" As a result, the FDA is now "considering applications for AstraZeneca PLC's Seroquel [quetiapine] and Eli Lilly and Co.'s Zyprexa [olanzapine] to treat bipolar disorder and schizophrenia in children and adolescents, and Pfizer, Inc.'s Geodon [ziprasidone] to treat bipolar disorder in children 10 to 17," comments the report. [read post]
27 May 2009, 12:44 am
"AstraZeneca LP v. [read post]
17 May 2009, 9:55 pm
A predecessor company to AstraZeneca began commercializing the first PPI compound, omeprazole, in 1989 under the... [read post]
5 May 2009, 5:57 am
"There's no evidence that AstraZeneca proffered a stronger warning that the FDA rejected. [read post]
15 Apr 2009, 4:44 am
Philip Morris Inc., 964 F. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
20 Mar 2009, 2:05 am
Squibb & Sons, Inc. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
15 Jan 2009, 6:39 pm
While Zyprexa has been subject of lawsuits, other drug makers such as Cephalon Inc. [read post]
13 Jan 2009, 8:41 am
800 Adept, Inc. v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
8 Jan 2009, 4:07 am
Astrazeneca Pharmaceuticals LP, 2008 WL 4832659 (M.D. [read post]
29 Dec 2008, 9:00 pm
AstraZeneca Pharmaceuticals LP, ___ F. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
